STOCK TITAN

Transactions of Managers and Closely Associated Persons

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Alvotech (ALVO) announced that its Chairman and CEO, Robert Wessman, has acquired 320,000 shares of the company at a price of ISK 1,255 per share. The transaction was executed at market opening and has been reported to the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) in accordance with regulatory requirements.

Loading...
Loading translation...

Positive

  • CEO's significant share purchase demonstrates confidence in company's future
  • Investment of approximately ISK 401.6 million (320,000 shares × ISK 1,255) by company insider

Negative

  • None.

News Market Reaction – ALVO

+3.20%
1 alert
+3.20% News Effect

On the day this news was published, ALVO gained 3.20%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition at the market opening of 320,000 shares in Alvotech at ISK 1,255 per share, by Robert Wessman, Chairman and CEO.


FAQ

How many Alvotech (ALVO) shares did CEO Robert Wessman purchase in May 2025?

Robert Wessman, Chairman and CEO of Alvotech, purchased 320,000 shares at ISK 1,255 per share at market opening.

What was the total value of Robert Wessman's Alvotech share purchase?

The total value of the share purchase was ISK 401.6 million (320,000 shares × ISK 1,255 per share).

What is the significance of ALVO CEO's share purchase in May 2025?

The significant share purchase by CEO Robert Wessman demonstrates insider confidence in the company's future prospects and aligns management interests with shareholders.

Where was Alvotech's insider transaction reported?

The transaction was reported to the Luxembourg Commission de Surveillance du Secteur Financier (CSSF).
Alvotech

NASDAQ:ALVO

View ALVO Stock Overview

ALVO Rankings

ALVO Latest News

ALVO Latest SEC Filings

ALVO Stock Data

975.31M
115.16M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Luxembourg
Luxembourg